The rapid spread of Zika virus (ZIKV), which causes microcephaly and Guillain-Barré syndrome, signals an urgency to identify therapeutics. Recent efforts to rescreen dengue virus human antibodies for ZIKV cross-neutralization activity showed antibody C10 as one of the most potent. To investigate the ability of the antibody to block fusion, we determined the cryoEM structures of the C10-ZIKV complex at pH levels mimicking the extracellular (pH8.0), early (pH6.5) and late endosomal (pH5.0) environments. The 4.0 Å resolution pH8.0 complex structure shows that the antibody binds to E proteins residues at the intra-dimer interface, and the virus quaternary structure-dependent inter-dimer and inter-raft interfaces. At pH6.5, antibody C10 locks all virus surface E proteins, and at pH5.0, it locks the E protein raft structure, suggesting that it prevents the structural rearrangement of the E proteins during the fusion event - a vital step for infection. This suggests antibody C10 could be a good therapeutic candidate.
CITATION STYLE
Zhang, S., Kostyuchenko, V. A., Ng, T. S., Lim, X. N., Ooi, J. S. G., Lambert, S., … Lok, S. M. (2016). Neutralization mechanism of a highly potent antibody against Zika virus. Nature Communications, 7. https://doi.org/10.1038/ncomms13679
Mendeley helps you to discover research relevant for your work.